ABSTRACT
While all interventional cardiologists have access to pharmacopeial texts and databases and are aware of the growing number of pharmacological agents in the armamentarium, questions arise as to the ideal agent or combination of agents in differing patient situations.
This superb text offers the reader coverage of all the major pharmacological t
TABLE OF CONTENTS
chapter 14|16 pages
Lipid-lowering agents
Andrew M. Tonkin and Omar Farouque Overview of clinical trials
chapter 18|16 pages
Role of systemic antineoplastic drugs in the treatment of restenosis after percutaneous stent implantation
Alfredo E. Rodriguez
chapter 22|12 pages
The application of controlled drug delivery principles to the development of drug-eluting stents
Kalpana R. Kamath, Kathleen M. Miller, and James J. Barry Background
chapter 25|16 pages
Utilization of antiproliferative and antimigratory compounds for the prevention of restenosis
Kalpana R. Kamath and James J. Barry Background
chapter 26|10 pages
Anti-inflammatory drugs, sirolimus, and inhibition of target of rapamycin and its effect on vascular diseases
Steven J. Adelman
chapter 27|14 pages
Anti-migratory drugs and mechanisms of action
Ivan De Scheerder, Xiaoshun Liu, and Yanming Huang Cell migration: a target for the control of restenosis
chapter 29|8 pages
Vasculoprotective approach for restenosis
Nicholas Kipshidze, Jean-François Tanguay, Alexandre C. Abizaid, and Antonio Colombo Endothelium and restenosis
chapter 31|8 pages
Gene therapy: role in myocardial protection
Alok S. Pachori, Luis G. Melo, and Victor J. Dzau tools and strategies for genetic manipulation
chapter 37|12 pages
Clinical trials in cellular therapy
Joanna J. Wykrzykowska, Munir Boodhwani, and Roger J. Laham
chapter 40|10 pages
Cardiovascular interventional pharmacology in the diabetic patient
Mitchell D. Weinberg and George D. Dangas intervention and related
chapter 41|10 pages
Atrial fibrillation during catheterization
Yves L. E. Van Belle, M. F. Scholten, and Luc J. Jordaens Incidence and prevalence
chapter 51|10 pages
Interventions for structural heart disease
Ralph Hein, Neil Wilson, and Horst Sievert Transcatheter ablation of septal hypertrophy
